Safeguard Scientifics to Realize at Least $36M in Initial Sale Proceeds from Eli Lilly's Acquisition of Avid Radiopharmaceuticals

Safeguard Scientifics, Inc. SFE today announced that it expects to receive a minimum of $36 million in initial sale proceeds from the successful completion of Eli Lilly and Company's LLY acquisition of partner company Avid Radiopharmaceuticals, Inc., which took place earlier today, a portion of which amounts will be held in escrow for approximately one year. Safeguard has deployed $12 million of capital in Avid since May 2007 for a 13% primary ownership stake. Therefore, the $36 million in expected minimum initial sale proceeds to be received will constitute a 3x cash-on-cash return.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!